medigraphic.com
ISSN 1405-1699 (Print)
Órgano Oficial del Colegio Mexicano de Alergia, Asma e Inmunología Pediátrica y de la Asociación Latinoamericana de Pediatría

2005, Number 1

<< Back Next >>

Alerg Asma Inmunol Pediatr 2005; 14 (1)

Immunodeficiencies by changes in phagocytic cells: A challenge for the pediatrician

Staines BAT, González SME, Guidos MHE, Hernández BVM, Espinosa RFJ, Espinosa PSE

Language: Spanish
References: 17
Page: 5-9
PDF size: 108.13 Kb.


ABSTRACT

Some clinical manifestations are common to the quantitative or qualitative defects in phagocytic cells. Their presence and persistence in a pediatric patient have to alert to the clinician on the diagnosis and reference to the specialist. Despite their low incidence, the knowledge of these diseases must be included in any pediatric program training and the allergist and clinical immunologist must be trained to detect them.


REFERENCES

  1. Rojas-Espinoza O, Arce-Paredes P. Fagocitosis mecanismos y consecuencias. Bioquímica 2004; 29: 55-67.

  2. Rich RR, Fleisher AT, Shearer TW, Kotzin LB, Schroder WH. Clinical Immunology Principles and practice. Second Edition. England Mosby 2001; Vol 1 37.1-37.18.

  3. Fleisher AT, Ballow M. Primary Immune Deficiencies: Presentation, Diagnosis, and Management. The Pediatric Clinics of North America 2000; 47(6): 1311-1337.

  4. Bonilla FA, Geha RS. Primary immunodeficiency disease. J Allergy Clin Immunol 2003; 111: S571-581.

  5. Lekstrom HJ, Gallin JI. Immunodeficiency Disease caused by defects in phagocytes. N Engl J Med 2000; 342: 1703-14.

  6. Hasui M, Sasaki M, Tsuji S, Yamamoto A. Dental infections as a cause of persistent fever in a patient with Chronic Granulomatous disease. Clinical Pediatrics 2004; 43: 171-173.

  7. Babior BM. NADPH oxidase. Current Opinion in Immunology 2004; 16: 42-47.

  8. Prando-Andrade C, Florez-Agudelo AP, López JA, Paiva MA, Costa Carvhalo BT, Condino-Neto A. Autosomal chronic granulomatous disease: case report and mutation analysis of two Brazilian sibilings. J Pediatr (Rio J) 2004; 80: 425-28.

  9. Agudelo-Florez FP, López JA, Redher J, Carneiro SMS, Costa CBT, Grumach AS, Condino-Neto. The use of reverse transcription-PCR for the diagnosis of X-linked chronic granulomatous disease. Braz J Med Biol Res 2004; 37: 625-633.

  10. Rosenzweig SD, Holland SM. Phagocyte immunodeficiencies and their infections. J Allergy Clin Immunol 2004; 113: 620-16.

  11. Margolis DM, Melnick DA, Alloing DW, Gallin IJ. Trimethoprim-sulfamethoxazol prophylaxis in the management of chronic granulomatous disease. The Journal Infect Disease 1990; 162: 723-726.

  12. Nunoi H, Ishibashi F, Misukami T, Hidaka F. Clinical evaluation of interferon-gamma treatment to chronic granulomatous disease patients with splice site mutations. Jpn J Infect Dis 2004; 57: 525-28.

  13. Gallin JI, Malech HL, Weening RS, Currnutte PG, Esekowitz AB. A controlled trail of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 1991; 324: 509-16.

  14. Chinen J, Puck JM. Successes and risk of gene therapy in primary immunodeficiencies. J Allergy Clin Immunol 2004; 113: 595-603.

  15. Rosa-Borges A, Sampaio MG, Condino-Neto A, Barreto OC, Nudelman V, Carneiro-Sampaio MS, Nogueira AS, Abreu FT, Redher J, Costa CB. Glucose-6-phosphate dehydrogenase deficiency with recurrent infections: Case report. J Pediatr (Rio J) 2001; 77(4): 331-36.

  16. Berrón PR, Yamasaki NM, Espinosa RF, Hernández BV, Ortega MJ. Tratamiento de la fase acelerada en el síndrome de Chediak-Higashi con gammaglobulina endovenosa. Bol Med Hosp Infant Mex 2002; 59: 297-300.

  17. García-Cruz ML, Camacho R, Ortega-Martell JA, Berrón-Pérez R. Registro de inmunodeficiencias primarias en pacientes mexicanos en una institución de tercer nivel: experiencia de 30 años. Alerg, Asma e Inmunol Pediátr 2002; 11(2): 48-66.




2020     |     www.medigraphic.com